Odnatron is indicated for the management of nausea and vomiting induced by cytotoxic chemotherapy and radiotherapy, as well as for the prevention and treatment of post-operative nausea and vomiting (PONV).
In the Paediatric Population, It is indicated for the management of chemotherapy-induced nausea and vomiting (CINV) in children aged ≥6 months and for the prevention and treatment of PONV in children aged ≥ 1 month.
